Artificial Intelligence in Healthcare

Aliyah is a Senior Medical Devices Analyst at GlobalData with a focus on Thematic Research. Her work includes comprehensive research and qualitative/quantitative analysis. She also has experience in market modeling and forecasts, especially in the Wound Care and In Vitro Diagnostics therapy areas. Prior to joining GlobalData, Aliyah worked as a Medical Engineer for the NHS where she was responsible for auditing, testing, and servicing medical equipment across several NHS Trusts. Aliyah has an MSc in Biomedical Engineering with a specialization in Neurotechnology from Imperial College London.

David is a Senior Healthcare Analyst at GlobalData in Canada where he helps lead the development of the Healthcare Intelligence Center, an offering geared towards delivering real-world data and granular insight into the healthcare sectors of payers, providers, and health IT. Before joining the Healthcare team, David was a Medical Device Analyst, supporting research across the segments of cardiology, neurology, and orthopedics. David completed his PhD in the field of regenerative biology at the University of Toronto and received a BSc from the University of Ontario in the field of pharmaceutical biotechnology.

Wafaa joined the thematic research team at GlobalData in March 2020. In her role as an analyst, she contributes to quantitative and qualitative analysis reports on disruptive themes and technologies. Wafaa focuses on the impact of themes, such as M&A and COVID-19 on the Pharma, Healthcare and Medical services sector. Prior to joining GlobalData, Wafaa studied for an MSc in Healthcare Management at City, University of London.

Kathryn is responsible for delivering all research projects within the pharma division of GlobalData. Previously, she was the Principal Analyst for the Digital Marketing Intelligence and Infectious Disease & Metabolic teams at Sociable Pharma. Kathryn’s pharmaceutical industry knowledge is comprehensive, gained from her time working within Healthcare at Home’s business strategic group, and during her time in analysis positions at Intelligentsia Worldwide and IMS Health. Prior to this, Kathryn worked within biotechnology commercialization at both UCB and Wyeth. Kathryn has an MSc in Biotechnology from University College Galway, Ireland, and a BSc in Plant and Microbial Biotechnology from University College Cork, Ireland.